KBC Group’s Novartis NVS Stock Holding History

KBC Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-31,826	Closed	-$2.29M	–	1332
2013 Q4	$2.29M	Sell	31,826 -13,004	-29%	-$904K	0.03%	485
2013 Q3	$3.08M	Hold	44,830	–	–	0.05%	402
2013 Q2	$2.84M	Buy	+44,830	New	+$2.92M	0.05%	413

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

KBC Group's NVS Position: Q1 2014 in Review

KBC Group sold out of Novartis (NVS) in Q1 2014, closing a stake of 31,826 shares — an estimated $2.29M sold.

KBC Group first reported a position in NVS in Q2 2013 and held it in 3 quarters. The position peaked at $3.08M in Q3 2013. 831 funds tracked by Wall St. Rank hold NVS as of Q1 2014.

KBC Group reported no remaining Novartis position as of Q1 2014 after selling out during the quarter.
KBC Group sold 31,826 Novartis shares in Q1 2014, an estimated $2.29M.
KBC Group first reported a position in Novartis in Q2 2013 and held it in 3 quarters.
KBC Group's Novartis position peaked at $3.08M in Q3 2013.
831 funds tracked by Wall St. Rank held Novartis as of Q1 2014.

Based on KBC Group's 13F filing for Q1 2014, filed 30 Apr 2014.